Afsaneh Shirani

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Venues

Journal of central nervous system disease

Therapeutic advances in neurological disorders

Brain sciences

Multiple sclerosis journal - experimental, translational and clinical

University of Nebraska Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Nebraska Medical Center Jul 01 2019

United States

Assistant Professor of Neurology :: Department of Neurological Sciences

Publications

Afsaneh Shirani, Anne H Cross, Olaf Stüve
Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database. Therapeutic advances in neurological disorders 17 (2024)
Afsaneh Shirani, Anne H Cross, Olaf Stüve
Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database. Therapeutic advances in neurological disorders 17 (2024)
Lakshman Arcot Jayagopal, Afsaneh Shirani, Kelly Cawcutt, Jie Chen, Ana Yuil-Valdes, Rana Zabad
Disseminated Aspergillosis in a Patient With Neurosarcoidosis: Persistent Contrast Enhancement in CNS Despite Prolonged Antifungal Treatment: A Case Report. Journal of central nervous system disease 15 (2023)
Navnika Gupta, Afsaneh Shirani, Lakshman Arcot Jayagopal, Ezequiel Piccione, Elizabeth Hartman, Rana Khalil Zabad
Anti-Neurofascin Antibodies Associated with White Matter Diseases of the Central Nervous System: A Red Flag or a Red Herring? Brain sciences 12 (9) (2022)
Afsaneh Shirani
It Is Time to Stop Racial Exclusion in Scholarly Citations. Journal of bioethical inquiry (2021)
Afsaneh Shirani, Scott R Dalton, Eric J Avery, Lakshman Arcot Jayagopal, Christina Meyer, Olaf Stüve, Rana Zabad
Lymphomatoid papulosis in a patient treated with glatiramer acetate and the glatiramoid Glatopa for multiple sclerosis: A case report. Journal of central nervous system disease 13 (2021)
Natalia Gonzalez Caldito, Afsaneh Shirani, Salter Amber, Olaf Stüve
Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database. Multiple sclerosis (Houndmills, Basingstoke, England) 27 (7) (2020)
Afsaneh Shirani, Peng Sun, Kathryn Trinkaus, Dana C Perantie, Ajit George, Robert T Naismith, Robert E Schmidt, Sheng-Kwei Song, Anne H Cross
Diffusion basis spectrum imaging for identifying pathologies in MS subtypes. Annals of clinical and translational neurology 6 (11) (2019)
Afsaneh Shirani, Anne H Cross, Robert T Naismith, null null
The association between handedness and clinicodemographic characteristics in people with multiple sclerosis: a brief report. Multiple sclerosis journal - experimental, translational and clinical 5 (1) (2019)
Afsaneh Shirani, Gregory F Wu, Caterina Giannini, Anne H Cross
A case of oligodendroglioma and multiple sclerosis: Occam's razor or Hickam's dictum? BMJ case reports 2018 (2018)
Afsaneh Shirani, Olaf Stüve
Natalizumab for Multiple Sclerosis: A Case in Point for the Impact of Translational Neuroimmunology. Journal of immunology (Baltimore, Md. : 1950) 198 (4) (2017)

Afsaneh Shirani.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Afsaneh Shirani